DBV Technologies
DBVT
#6651
Rank
HK$5.29 B
Marketcap
HK$131.87
Share price
21.94%
Change (1 day)
385.69%
Change (1 year)

P/E ratio for DBV Technologies (DBVT)

P/E ratio as of December 2025 (TTM): -2.97

According to DBV Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.96814. At the end of 2023 the company had a P/E ratio of -0.5016.

P/E ratio history for DBV Technologies from 2021 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2023-0.50161.63%
2022-0.493531.51%
2021-0.37530.28%
2020-0.3742-60.98%
2019-0.9591125.24%
2018-0.4258-69.01%
2017-1.37-51.88%
2016-2.85-55.23%
2015-6.387.73%
2014-5.92

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Ionis Pharmaceuticals
IONS
-50.5 1,600.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
> 1000-161,345.76%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.